Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|16|7|661-666

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.16, Iss.7, 2014-07, pp. : 661-666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of sitagliptin on counter‐regulatory and incretin hormones during acute hypoglycaemia in patients with type 1 diabetes: a randomized double‐blind placebo‐controlled crossover study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 546-553

John Wiley & Sons Inc

Access to resources Recommend Favorite

Second-Line Therapy in Refractory Pancreatic Cancer. Results of a Phase II Study

By  

Oncology Research and Treatment, Vol. 32, Iss. 3, 2009-02 ,pp. : 99-102

Karger

Access to resources Recommend Favorite

A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies

By Barnett Anthony   Allsworth Josie   Jameson Kevin   Mann Rachel  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1493-1507

Informa Healthcare

Access to resources Recommend Favorite

Endocrine Therapy in Pancreatic Carcinoma

By  

Oncology, Vol. 55, Iss. 1, 1998-12 ,pp. : 17-22

Karger

Access to resources Recommend Favorite

Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies

By Meece Jerry  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 933-944

Informa Healthcare

Access to resources Recommend Favorite